Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.
KMID : 0624620150480110624
BMB Reports
2015 Volume.48 No. 11 p.624 ~ p.629
Inhibitory effects of lysozyme on endothelial protein C receptor shedding in vitro and in vivo
Ku Sae-Kwang

Yoon Eun-Kyung
Lee Hyun-Gyu
Han Min-Su
Lee Tae-Ho
Bae Jong-Sup
Abstract
Lysozyme protects us from the ever-present danger of bacterial infection and binds to bacterial lipopolysaccharide (LPS) with high affinity. Beyond its role in the activation of protein C, the endothelial cell protein C receptor (EPCR) plays an important role in the cytoprotective pathway. EPCR can be shed from the cell surface, which is mediated by tumor necrosis factor-¥á converting enzyme (TACE). However, little is known about the effects of lysozyme on EPCR shedding. We investigated this issue by monitoring the effects of lysozyme on phorbol- 12-myristate 13-acetate (PMA)-, tumor necrosis factor (TNF)-¥á-, interleukin (IL)-1¥â-, and cecal ligation and puncture (CLP)-mediated EPCR shedding and underlying mechanism. Data demonstrate that lysozyme induced potent inhibition of PMA-, TNF-¥á-, IL-1¥â-, and CLP-induced EPCR shedding. Lysozyme also inhibited the expression and activity of PMA-induced TACE in endothelial cells. These results demonstrate the potential of lysozyme as an anti-EPCR shedding reagent against PMA-mediated and CLP-mediated EPCR shedding.
KEYWORD
CLP, EPCR shedding, Lysozyme, Vascular inflammation
FullTexts / Linksout information
Listed journal information
SCI(E) ÇмúÁøÈïÀç´Ü(KCI) ´ëÇÑÀÇÇÐȸ ȸ¿ø